BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Baxter
Colorcon
Harvard Business School
Novartis
Citi
QuintilesIMS
UBS
Covington
McKesson

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,849,752

« Back to Dashboard

Summary for Patent: 5,849,752
Title: Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification
Abstract:The invention relates to the new monohydrate of 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo-[4.3.0]non-8-yl)6-fluoro-1,4-dihyd ro-8-methoxy-4-oxo-3-quinolinecarboxylic acid hydrochloride (CDCH), a process for its preparation and pharmaceutical formulations which comprise this monohydrate as the active compound.
Inventor(s): Grunenberg; Alfons (Dormagen, DE), Bosche; Patrick (Odenthal, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:08/760,543
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,849,752

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER moxifloxacin hydrochloride SOLUTION;IV (INFUSION) 021277-001 Nov 30, 2001 AP RX Yes Yes ➤ Subscribe ➤ Subscribe METHOD OF COMBATING BACTERIA IN A PATIENT ➤ Subscribe
Bayer Hlthcare AVELOX moxifloxacin hydrochloride TABLET;ORAL 021085-001 Dec 10, 1999 AB RX Yes Yes ➤ Subscribe ➤ Subscribe METHOD OF COMBATING BACTERIA IN A PATIENT ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,849,752

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 46 249.1Dec 12, 1995

International Patents Family Members for US Patent 5,849,752

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary 226521 ➤ Subscribe
Hungary 9603428 ➤ Subscribe
Croatia P960558 ➤ Subscribe
Spain 2179910 ➤ Subscribe
European Patent Office 0780390 ➤ Subscribe PA2004012,C0780390 Lithuania ➤ Subscribe
European Patent Office 0780390 ➤ Subscribe PA2004012 Lithuania ➤ Subscribe
Estonia 03474 ➤ Subscribe
Estonia 9600201 ➤ Subscribe
Denmark 0780390 ➤ Subscribe
Germany 19546249 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Mallinckrodt
Covington
Teva
Julphar
McKinsey
Cipla
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot